Post by LivaNova

LivaNova team members across many departments came together for SLEEP 2026, the 40th annual meeting of the Associated Professional Sleep Societies. They were thrilled to showcase the progress we are making in Obstructive Sleep Apnea, including recent FDA premarket approval and newly released responder data. Learn more about our proximal hypoglossal nerve stimulation (pHGNS) for Obstructive Sleep Apnea (OSA) at https://lnkd.in/dit-yC2A